Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model.

@article{Zhou2019BrimonidineEI,
  title={Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model.},
  author={Xujiao Zhou and Ting Zhang and Jihong Wu},
  journal={Experimental eye research},
  year={2019},
  pages={
          107833
        }
}
Glaucoma is a multifactorial disease in which retinal ganglion cells (RGCs) undergo excitotoxic damage, leading to their degeneration. The α2-adrenoceptor (α2-AR) agonist brimonidine exerts a neuroprotective effect by regulating postsynaptic excitatory N-methyl-D-aspartate (NMDA) receptor activity in RGCs. However, researchers have not clearly determined whether or how brimonidine regulates inhibitory synaptic transmission in rat models of chronic glaucoma. Whole-cell voltage-clamp and current… Expand
4 Citations
Synapse and Receptor Alterations in Two Different S100B-Induced Glaucoma-Like Models
TLDR
While inhibitory post-synapses remained unchanged in both models, excitatory post- synapse degenerated in animals with intraocular S100B injection, which could be explained by remodeling followed by degeneration. Expand
A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma
TLDR
In the MCE model, IOP elevation was drastically reduced by melatonin/agomelatine with higher efficacy than that of timolol or brimonidine, two drugs commonly used to treat glaucoma. Expand
The Role of Adrenoceptors in the Retina
TLDR
Since catecholamines and respective bindings sites have been characterized in the retina, the literature with regard to retinal expression, distribution and function of alpha1 (α1)-, alpha2 (α2)-, and beta (β)-adrenoceptors (ARs) is systematically reviewed. Expand
A novel rat model of ocular hypertension by a single intracameral injection of cross‐linked hyaluronic acid hydrogel (Healaflow®)
TLDR
Intracameral injection of Healaflow is an effective approach to induce glaucomatous neurodegeneration in rats and Six3 and Prss56 may be involved in the pathogenesis of progressive glau comatous damage. Expand

References

SHOWING 1-10 OF 27 REFERENCES
Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
TLDR
A new therapeutic approach based on neuromodulation, instead of direct inhibition, of theNMDA receptor for the treatment of glaucoma and other CNS disorders associated with NMDA receptor overactivation is suggested. Expand
Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
TLDR
The results of western blotting and immunostaining showed that glutamic acid decarboxylase 65/67 and GABA deficits persisted in glaucomatous retinas and that these deficits were reversed by PNU-282987. Expand
Differential Modulation of GABAA and NMDA Receptors by an α7-nicotinic Acetylcholine Receptor Agonist in Chronic Glaucoma
Presynaptic modulation of γ-aminobutyric acid (GABA) release by an alpha7 nicotinic acetylcholine receptor (α7-nAChR) agonist promotes retinal ganglion cell (RGC) survival and function, as suggestedExpand
Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma
TLDR
The results showed that the activation of 5-HT1A receptors in retinas facilitated presynaptic GABA release functions by suppressing cAMP-PKA signaling and decreasing PKA phosphorylation, which could lead to the de-excitation of RGC circuits and suppress excitotoxic processes in glaucoma. Expand
Activation of group I metabotropic glutamate receptors regulates the excitability of rat retinal ganglion cells by suppressing Kir and Ih
TLDR
It is suggested that activation of mGluR I regulates the excitability of rat RGCs by inhibiting Kir and Ih. Expand
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons
TLDR
Continuous and systemic treatment with brimonidine by subcutaneous injection significantly improved retinal ganglion cell survival with exposure to elevated ocular pressure and suggests its neuroprotective effects are relevant not only at the cell body, but throughout the entire optic projection. Expand
Group I mGluR-Mediated Inhibition of Kir Channels Contributes to Retinal Müller Cell Gliosis in a Rat Chronic Ocular Hypertension Model
TLDR
It is concluded that overactivation of mGluR5 by excessive extracellular glutamate in COH rats could contribute to Müller cell gliosis by suppressing Kir channels. Expand
Brimonidine promotes axon growth after optic nerve injury through Erk phosphorylation
TLDR
Results indicate that BMD promotes optic nerve regeneration via the activation of Erk1/2 through the activationof Erk 1/2 in an optic nerve injury model. Expand
Neuroprotective Effect of Memantine in Different Retinal Injury Models in Rats
TLDR
The protective effect of memantine suggests that excessive stimulation of NMDA receptors by glutamate is involved in causing cell damage in these RGC injury models. Expand
Ethanol enhances GABAergic transmission onto dopamine neurons in the ventral tegmental area of the rat.
TLDR
The present results indicate that ethanol increases postsynaptic GABA(A) receptor sensitivity, enhances action potential-independent GABA release onto VTA-DA neurons, and that this latter effect is independent of GABA(B) auto-receptor inhibition of GABA release. Expand
...
1
2
3
...